APT Medical Inc. APT Medical Inc.

APT Medical Inc.

688617

Peringkat dalam Saham #3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Harga Saham
$38.62
Kapitalisasi Pasar
$5.47B
Perubahan (1 hari)
0.19%
Perubahan (1 tahun)
-17.07%
Negara
CN
Perdagangan APT Medical Inc. (688617)

Kategori

Healthcare
Laba untuk APT Medical Inc. (688617)
Laba pada Jun 2026 TTM: $158.75M
Menurut laporan keuangan terbaru dari APT Medical Inc., laba saat ini perusahaan adalah $158.75M. Pada tahun 2024, perusahaan memperoleh laba sebesar $102.20M, peningkatan dibandingkan laba tahun 2023 sebesar $84.25M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk APT Medical Inc. dari 2017 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $158.75M 18.63%
2025 $133.82M 30.94%
2024 $102.20M 21.31%
2023 $84.25M 47.08%
2022 $57.28M 64.33%
2021 $34.86M 87.86%
2020 $18.55M 41.43%
2019 $13.12M 288.78%
2018 $3.37M -29.16%
2017 $4.76M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$6.56B 4,033.47%
US
$6.60B 4,059.29%
IE
$5.15B 3,142.78%
US
$3.86B 2,332.08%
US
$3.25B 1,947.21%
DE